ARCH Venture Management as of Dec. 31, 2024
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 9 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Beam Therapeutics (BEAM) | 48.9 | $113M | 4.5M | 24.80 | |
| Rapport Therapeutics (RAPP) | 28.7 | $66M | 3.7M | 17.74 | |
| Erasca (ERAS) | 12.1 | $28M | 11M | 2.51 | |
| Verve Therapeutics (VERV) | 4.9 | $11M | 2.0M | 5.64 | |
| Gossamer Bio (GOSS) | 3.2 | $7.3M | 8.1M | 0.90 | |
| Singular Genomics Systems Com New | 1.1 | $2.5M | 127k | 19.43 | |
| Q32 Bio (QTTB) | 0.5 | $1.1M | 321k | 3.44 | |
| Unity Biotechnology Com New | 0.4 | $981k | 1.0M | 0.98 | |
| Cero Therapeutics Holdings Class A Com | 0.2 | $564k | 9.4M | 0.06 |
